Prolto(SZ:002769)2022-04-29 16:00Financial Performance - The company's operating revenue for 2021 was ¥2,572,254,463.66, representing a decrease of 20.98% compared to ¥3,255,111,387.16 in 2020[18]. - The net profit attributable to shareholders for 2021 was ¥36,704,464.31, down 45.78% from ¥67,692,388.04 in 2020[18]. - The net profit after deducting non-recurring gains and losses was ¥14,239,137.39, a decline of 72.17% from ¥51,172,265.12 in 2020[18]. - The total assets at the end of 2021 were 3,806,664,796.61 CNY, a decrease of 37.60% compared to the end of 2020[24]. - The basic and diluted earnings per share for 2021 were both 0.10 CNY, down 44.44% from 0.18 CNY in 2020[24]. - The net cash flow from operating activities was -404,901,243.21 CNY, a decline of 3,799.35% compared to the previous year[24]. - The weighted average return on equity was 2.51% for 2021, down from 4.76% in 2020[24]. - The company reported a total of 22,465,326.92 CNY in non-recurring gains and losses for 2021, compared to 16,520,122.92 CNY in 2020[25]. - The operating profit for the year was CNY 49,016,000, down 44.68% year-on-year, while the net profit attributable to shareholders was CNY 36,704,500, a decline of 45.78%[43]. - The transaction business accounted for 84.92% of total revenue, totaling CNY 2,184,481,363.38, which represents a 24.23% decrease from the previous year[45]. - Service business revenue increased by 23.66% to CNY 292,377,525.01, making up 11.37% of total revenue[45]. Business Operations - The company has not changed its main business since its listing, maintaining its focus on supply chain management[17]. - The company has expanded its business segments to include ICT supply chain management, medical B2B, financial leasing, cross-border e-commerce, and municipal infrastructure[30]. - The company aims to enhance supply chain value through professional and customized management services, responding to the increasing demand for efficient collaboration and rapid response capabilities[30]. - The company provides integrated supply chain solutions, including design, optimization, inventory management, and logistics support, to enhance supply chain efficiency and innovation for clients[33]. - The company is positioned as a leading player in the domestic supply chain management industry, supported by government policies promoting supply chain innovation and application[30]. - The company has established strategic partnerships with international medical device manufacturers, facilitating efficient procurement for domestic hospitals and institutions, thus reducing costs and procurement cycles[34]. - The financing leasing business is strategically integrated with existing operations, helping medical clients manage capital allocation effectively and enhancing the company's profitability and competitive edge[34]. - The cross-border e-commerce business offers comprehensive supply chain management solutions, including customs clearance and overseas procurement, leveraging the company's expertise in import and export[35]. - The company is expanding its supply chain management services to municipal infrastructure and construction sectors, providing tailored solutions to enhance clients' competitiveness[36]. Risk Management - The company emphasizes the importance of risk awareness for investors regarding future operational plans[4]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the audit report[24]. - Risks include potential declines in business volume due to the ongoing COVID-19 pandemic and macroeconomic changes, as well as reliance on the ICT industry[85]. - The company faces foreign exchange risk due to significant overseas procurement, which it mitigates through fixed-income foreign exchange products[85]. - The company emphasizes the importance of managing accounts receivable risks by focusing on high-quality clients and enhancing credit evaluation processes[87]. Governance and Compliance - The company adheres strictly to legal regulations and its information disclosure management system, ensuring timely and accurate information dissemination to all investors[98]. - The company operates independently from its controlling shareholders in terms of business, personnel, assets, institutions, and finances, ensuring complete operational autonomy[99]. - The company has established an independent financial department with its own accounting system and tax obligations, without providing guarantees for related parties[104]. - The company has a complete supply chain management business system and sales system, independently operating in the market without interference from controlling shareholders[100]. - The company has a well-established organizational structure, allowing independent operation of its various departments[103]. - The company’s governance practices align with the regulations set forth by the China Securities Regulatory Commission, with no significant discrepancies noted[98]. Employee and Management - The total number of employees at the end of the reporting period was 358, with 206 in the parent company and 152 in major subsidiaries[134]. - The company has a dedicated human resources department and management team, ensuring that senior management does not hold positions in controlling entities[101]. - The company implements a compensation policy of "fixed salary + variable salary + year-end bonus," ensuring compliance with national labor regulations and providing social security benefits[135][136]. - The company has established a performance evaluation system linking the remuneration of management to company performance and individual performance[120]. - The management team has extensive experience in finance and supply chain management, contributing to strategic decision-making[113]. Future Outlook - The company aims to leverage technology to improve service delivery and customer satisfaction in the supply chain sector[112]. - Future growth strategies include market expansion and potential mergers and acquisitions to enhance competitive positioning[112]. - The company has provided a revenue guidance of 1.5 billion RMB for the next fiscal year, which reflects an expected growth of 25%[117]. - New product launches are expected to contribute an additional 300 million RMB in revenue, with a focus on enhancing supply chain solutions[117]. - The company is investing 100 million RMB in R&D for new technologies aimed at improving operational efficiency[117]. - Market expansion plans include entering two new provinces, which are projected to increase market share by 10%[117]. Shareholder Information - The company proposed a cash dividend of 0.20 CNY per 10 shares, totaling 7,466,361.08 CNY, which represents 100% of the profit distribution[139]. - The largest shareholder, Mr. Chen Shuzhi, transferred voting rights for 71,559,567 shares (19.18% of total shares) to Green Gold Investment[189]. - Following the expiration of the voting rights entrustment, Mr. Chen Shuzhi regained control with 64,149,567 shares (17.18% of total shares)[190]. - The company has a significant ownership structure, with major shareholders holding 10.66% of the shares each[111]. - The total number of shares is 373,318,000, with 29.35% being restricted shares and 70.65% being unrestricted shares[193]. Legal Matters - The company is involved in ongoing litigation with Guangzhou Junya Medical Equipment Co., with a disputed amount of 41.36 million yuan, which has been ruled but is still partially in execution[170]. - Another ongoing case involves a dispute with China Railway 10th Bureau Group, with a disputed amount of 41.09 million yuan, which has reached a settlement agreement but is still in execution[170]. - The company has no significant penalties or rectification issues during the reporting period[171].